Does RIBOCICLIB Cause Metastasis? 404 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 404 reports of Metastasis have been filed in association with RIBOCICLIB (KISQALI). This represents 1.4% of all adverse event reports for RIBOCICLIB.
404
Reports of Metastasis with RIBOCICLIB
1.4%
of all RIBOCICLIB reports
66
Deaths
105
Hospitalizations
How Dangerous Is Metastasis From RIBOCICLIB?
Of the 404 reports, 66 (16.3%) resulted in death, 105 (26.0%) required hospitalization, and 39 (9.7%) were considered life-threatening.
Is Metastasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 404 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Metastasis?
LETROZOLE (284)
TRASTUZUMAB (273)
CYCLOPHOSPHAMIDE (267)
FULVESTRANT (262)
CAPECITABINE (233)
BEVACIZUMAB (225)
CARBOPLATIN (206)
LEUPROLIDE (201)
PACLITAXEL (198)
RITUXIMAB (191)
Which RIBOCICLIB Alternatives Have Lower Metastasis Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN